Tianjin Ringpu Bio-Technology Co.,Ltd. Stock

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. 31/07/2026 5-day change 1st Jan Change
17.02 CNY +1.73% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. +9.59% -9.32%

Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 7.73B 1.14B 995M 926M 850M 1.61B 109B 1.63B 10.91B 4.28B 54.37B 4.3B 4.2B 182B P/E 2026 *
17.4x
P/E 2027 * 15x
Enterprise Value 8.25B 1.22B 1.06B 988M 907M 1.71B 117B 1.74B 11.65B 4.57B 58.03B 4.59B 4.48B 195B EV / Sales 2026 *
2.19x
EV / Sales 2027 * 1.89x
Free-Float
51.96%
Yield 2026 *
1.76%
Yield 2027 * 2.84%
06-10 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-27 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-28 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
30/10/25 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
24/10/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25/08/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
14/07/25 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
14/06/25 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
30/04/25 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
30/04/25 Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on November 4, 2024, has closed with 6,997,751 shares, representing 1.52% for CNY 129.98 million. CI
1 day+1.73%
1 week+9.59%
1 month+13.16%
3 months-5.44%
6 months-14.56%
Current year-9.32%
1 week 15.43
Extreme 15.43
17.1
1 month 15.21
Extreme 15.21
17.1
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
24.03
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
28.9
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 30/03/2023
Director of Finance/CFO 51 28/04/2022
Corporate Officer/Principal 45 27/10/2020
Director TitleAgeSince
Chairman 63 12/05/2008
Director/Board Member 53 25/12/2019
Director/Board Member 51 10/01/2020
Date Insider Type Main position Quantity % Market Cap.
24/05/23 Buy 3,000 0.0009%
23/05/23 Buy 1,000 0.0003%
04/09/20 Sell

Chief Executive Officer

47,300 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
+1.73%+9.59%-20.13%-9.32% 1.14B
+1.66%+2.57%-47.56%-58.34% 32.4B
-0.34%+5.86%+91.23%+120.30% 13.17B
+0.48%+5.65%-15.72%+1.69% 3.84B
-1.17%+1.66%-0.74%+22.73% 3.25B
+7.85%+12.96%+48.36%+24.53% 2.04B
-1.45%+0.74%+2.10%+24.72% 1.89B
-0.33%+6.74%+39.14%+144.98% 1.47B
+1.24%+4.31%-13.95%-46.52% 989M
+0.41%+2.10%-3.31%-19.34% 976M
Average +1.01%+4.72%+7.94%+20.54% 6.12B
Weighted average by Cap. +1.04%+3.78%-4.60%+0.16%

Financials

2026 *2027 *
Net sales 3.77B 558M 485M 451M 414M 783M 53.25B 795M 5.32B 2.09B 26.51B 2.09B 2.05B 88.89B 4.26B 631M 548M 510M 468M 885M 60.19B 898M 6.01B 2.36B 29.97B 2.37B 2.32B 100B
Net income 441M 65.3M 56.76M 52.83M 48.51M 91.6M 6.23B 93.02M 623M 244M 3.1B 245M 240M 10.41B 527M 78.08M 67.88M 63.18M 58M 110M 7.45B 111M 745M 292M 3.71B 293M 287M 12.44B
Net Debt 519M 76.89M 66.84M 62.21M 57.12M 108M 7.34B 110M 733M 288M 3.65B 289M 282M 12.25B 337M 49.89M 43.37M 40.37M 37.06M 69.99M 4.76B 71.07M 476M 187M 2.37B 187M 183M 7.95B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
31/07/26 CN¥17.02 +1.73% 7,088,800
30/07/26 CN¥16.73 +4.69% 10,144,724
29/07/26 CN¥15.98 +1.65% 3,463,800
28/07/26 CN¥15.72 -0.38% 2,046,300
27/07/26 CN¥15.78 +1.61% 2,792,657
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
17.02CNY
Average target price
20.41CNY
Spread / Average Target
+19.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock